On air · 2 of 3 networks
ACROBiosystems AG
- acrobiosystems.com
- Healthcare & Life Sciences
- CH
- 7 employees
ACROBiosystems AG’s ads on LinkedIn, Meta and Google, recorded by adsrunning. Browse the latest here for free. Sign up free to see all 169. Watch ACROBiosystems AG with Starter to get each new one in your feed.
Watchlist with Starter · $49/mo
| Network | Status | Live ads | Nov 2025LinkedIn activity · 52 weeksOct 2026 | Checked | Next step |
|---|---|---|---|---|---|
| Running | 1 | Checked 29 Oct 2026 | See all 169 ads → | ||
| Meta | Not checked | — | |||
| Running | 10k+ | Ads on the Google Ads Transparency Center | Checked 29 Oct 2026 | Collect them with the API → |
ACROBiosystems AG has 1 live LinkedIn ad. We recorded 10k+ Google ads on 29 Oct 2026.
Latest ads
- LINKEDIN · IMAGESince 20 Oct 2026
Webinar Invitation | Optimizing Immune Cell Culture for Cell Therapy Manufacturing How can you achieve efficient expansion and high cell purity across different immune cell types? Join our upcoming webinar to explore a flexible two-component culture medium system designed to support T cells, NK cells, and γδ T cells. 🔬 Key Highlights: 🔹 A customizable culture system for diverse immune cell types 🔹 Expansion of up to 3,000-fold for T cells, 1,000-fold for NK cells, and 17,600-fold for γδ T cells 🔹 Cell purity reaching 99% for T cells, 97% for NK cells, and 93% for γδ T cells 🔹 Practical strategies to streamline culture optimization for immune cell therapy manufacturing 📅 Save your spot and discover a flexible approach to immune cell culture! 👉 Register now: https://lnkd.in/gtZ5MWkV/?utm_campaign=EU_Keyproducts&utm_source=linkedin&utm_medium=paid&utm_id=818919203&hsa_acc=514352614&hsa_cam=818919203&hsa_grp=914869116&hsa_ad=1652268716&hsa_net=linkedin&hsa_ver=3
- LINKEDIN · IMAGESince 15 Oct 2026
🔬Webinar Invitation: Analysis of Dimeric Activin E in Biological Samples Activin E is an emerging therapeutic target for obesity and metabolic diseases. Reliable quantification of circulating dimeric Activin E is essential for supporting pharmacodynamic studies in drug development. In this webinar, discover how a dimer-specific Activin E ELISA was developed and validated, with its performance compared against LC-MS/MS using human serum samples. What you’ll learn: 🔹 Development and validation of a dimeric Activin E ELISA 🔹 Assessment of assay accuracy and specificity 🔹 Comparison with LC-MS/MS 🔹 Pharmacodynamic evaluation in human and NHP siRNA models 🎥 Click to Register: https://lnkd.in/gZ8B-Va3/?utm_campaign=EU_Keyproducts&utm_source=linkedin&utm_medium=paid&utm_id=818919203&hsa_acc=514352614&hsa_cam=818919203&hsa_grp=912846566&hsa_ad=1644569646&hsa_net=linkedin&hsa_ver=3
- LINKEDIN · IMAGESince 28 Sept 2026
📢[Live Webinar] Advancing ADC Development: From Characterization to Bioanalysis Antibody-drug conjugates (ADCs) combine the targeting capabilities of antibodies with the potent activity of cytotoxic payloads, creating unique analytical challenges throughout drug development. Robust bioanalytical strategies are essential for characterizing ADC binding properties and addressing critical challenges in pharmacokinetic (PK) assessment. 📅 Date: Oct 27, 2026 ⏱ Time: 10 AM PT | 1 PM ET | 5 PM GMT | 7 PM CET Highlights: 🔸 Target and Fc receptor binding characterization using SPR/BLI 🔸 Key PK bioanalysis challenges, including DAR sensitivity and payload biotransformation 🔸 Soluble target interference and ADA assessment 🔸 Streamlined bioanalytical solutions for ADC development You are welcome to reserve your seat to attend the live session or watch the recording at your convenience afterward.
- LINKEDIN · IMAGESince 23 Sept 2026
🤝 ACROBiosystems a hâte de vous rencontrer à Paris ! 📍 The HIVE Innovation Center · Campus Grand Park · Villejuif, Paris · Kadans Science Partner 🤝 Notre nouveau hub nous rapproche de nos clients, de nos partenaires et de la communauté croissante des sciences de la vie dans la région, créant ainsi de nouvelles opportunités pour échanger, collaborer et grandir ensemble. 🧬 Chez ACROBiosystems, notre mission est de contribuer à relever les défis du développement de médicaments grâce à des outils et des solutions innovants, de la découverte jusqu’à la clinique. Avec une présence locale renforcée en France, nous sommes impatients de collaborer encore plus étroitement avec les scientifiques et les innovateurs afin de simplifier et d’accélérer le développement de médicaments toujours plus performants. 🌱 Un nouvel espace. Des liens plus forts. De nouvelles opportunités pour créer ensemble un impact durable.
- LINKEDIN · IMAGESince 17 Sept 2026
Explore biomolecules the way drug developers think. Instead of searching through product lists, start with your therapeutic area or target molecule. 🌌 Meet ACRO's Starry Ocean Map—a visual discovery tool connecting target molecules with relevant proteins, antibodies, assay kits, and cell lines. Pick your molecule. Discover what you need. Light up your drug-discovery journey.
- LINKEDIN · IMAGESince 17 Sept 2026
Plus proches de nos clients. Plus proches de l’avenir. 🤝 ACROBiosystems a hâte de vous rencontrer à Paris! 📍 The HIVE Innovation Center · Campus Grand Park · Villejuif, Paris Kadans Science Partner 🤝 Our new hub brings us closer to customers, partners, and the growing life sciences community in the region — creating new opportunities to connect, collaborate, and grow together. 🧬 At ACROBiosystems, our mission is to help overcome challenges in drug development with innovative tools and solutions from discovery to the clinic. With a stronger local presence in France, we look forward to working even more closely with scientists and innovators to help simplify and accelerate the development of better medicines. 🌱 A new space. Stronger connections. More opportunities to make an impact together.
6 of 169 adsSign up to see every ACROBiosystems AG ad, filter by format and date, and get alerts on new ones.
See all 169 adsWatch the companies you care about.
Filter every ad by industry, country, format and network, and get alerts when a company you watch starts running new ads.